Madonella

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Madonella

What is Madonella? (Ethinyl Estradiol and Levonorgestrel)

Property Description
Active Ingredients Ethinyl Estradiol and Levonorgestrel
Form Oral Tablet (usually sugar-coated)
Pharmacological Class Combined Oral Contraceptive (COC)
Common Use Prevention of Pregnancy (Contraception)
Origin Synthetic Steroid Derivatives
Status Prescription-Only (Rx)

The medicinal product Madonella is a specific, prescription-only formulation containing the synthetic steroid hormones Ethinyl Estradiol and Levonorgestrel. This medication is classified within the Combined Oral Contraceptive (COC) group, which is recognized as a clinically effective method for preventing pregnancy. It is designed for oral administration as a tablet.

Compositional Nature and Origin

The formulation is characterized as a combination product, leveraging the synergistic action of two different hormone types: Ethinyl Estradiol, which functions as the estrogen component, and Levonorgestrel, which serves as the progestin component. Both of these active ingredients are entirely synthetic derivatives. The specific strength of the Ethinyl Estradiol component in this formulation is clinically recognized as a factor in determining the overall hormonal balance and profile of the contraceptive.

Primary Purpose and Core Function

The sole therapeutic use of this combined hormonal preparation is for contraception, ensuring the effective prevention of pregnancy in women of reproductive potential. The high effectiveness of this type of hormonal product, primarily through ovulation suppression, is a long-established standard of care. This means the core function is achieved by preventing the release of an egg from the ovaries. The product achieves this goal through a dual-action mechanism that also includes modifying the cervical mucus and the endometrium, which collectively provides a medically sound barrier against conception.

What side effects are possible with Madonella?

Possible Side Effects and Safety Information

The safety profile of Madonella, a medicine often containing levonorgestrel, is defined by regulatory bodies through specific adverse reaction classifications and mandated safety restrictions.

Adverse reaction scope

  • Key Adverse Reaction Categories: Adverse effects are formally listed and grouped by their frequency of occurrence (e.g., Very Common, Common, Uncommon) and the affected body system (System Organ Class, SOC).
  • System-Organ Classes Involved: Commonly reported adverse reactions typically involve the Gastrointestinal System (e.g., nausea, abdominal pain), Nervous System (e.g., headache, dizziness), and Reproductive System and Breast Disorders (e.g., breast tenderness, irregular or heavier menstrual bleeding).

Serious Adverse Reactions (as documented in regulatory sources)

Although rare, the official labeling for products of this class documents the risk of serious health events, including:

  • Thromboembolic Events (e.g., deep vein thrombosis, pulmonary embolism).
  • The possibility of an Ectopic Pregnancy must be considered in women who experience lower abdominal pain or become pregnant after use, as stated by the regulator.

Safety-Related Restrictions or Limitations

  • Contraindications: Use is formally restricted in cases of known or suspected pregnancy, a history of certain thromboembolic disorders, severe liver disease, and known or suspected estrogen- or progestin-sensitive cancers.
  • Time-Related Patterns: Irregular vaginal bleeding or spotting may occur, particularly after initiation or use. If menstrual bleeding is delayed beyond one week, the regulator specifies that pregnancy must be ruled out.

Regulatory Safety Summary: The official safety information structures the drug's risk profile by formally classifying all documented adverse reactions and establishing explicit constraints on use. This framework mandates specific patient evaluations for serious risks like ectopic pregnancy and requires exclusion of the medicine for patients with defined high-risk conditions.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for an acute overdose of Madonella (Ethinyl Estradiol and Levonorgestrel) defines the event as generally not expected to be life-threatening. However, immediate action is mandated upon suspicion of an overdose.

Documented Manifestations and Classification

Classification Manifestations & Actions
Severity Typically classified as not life-threatening [NIH/MedlinePlus].
Common Signs Nausea, vomiting, headache, fatigue, and potential withdrawal bleeding (vaginal bleeding) [FDA Labeling; NIH/MedlinePlus].

Required Emergency Actions

Official government guidance requires specific steps be taken immediately following a suspected overdose, as no specific antidote is known for this combined hormonal formulation [EMA/SmPC].

  • Seek Medical Help Right Away: Contacting a healthcare provider or a poison control center is the mandated first step for urgent guidance [NIH/MedlinePlus].
  • Management: Treatment is defined as symptomatic and supportive, addressing the resulting manifestations rather than the underlying exposure [EMA/SmPC].

These regulatory statements confirm that while the overdose is generally mild, immediate medical consultation is required, and management will focus on support and observation.

Therapeutic Uses of Madonella

What Madonella Treats: Main Uses and Benefits


The combined formulation of Ethinyl Estradiol and Levonorgestrel is used across several gynecological and symptomatic domains.

Primary Therapeutic Role: Pregnancy Prevention and Cycle Stability

The medication's fundamental purpose is to provide highly reliable contraception for women of reproductive age. Beyond fertility control, it is commonly used to help with managing irregular menstruation, which assists with establishing a clear, predictable cycle schedule. This therapeutic action supports patients during episodes of heightened discomfort and may assist with maintaining functional stability.

Symptomatic Management and Benefits

Madonella is also applied across domains where additional symptomatic support is needed. It is relevant for managing symptoms related to physical discomfort, such as severe monthly pain (dysmenorrhea) and excessively heavy blood loss (menorrhagia), and helps address androgen-related symptoms like acne vulgaris and unwanted hair growth (hirsutism). Applied in chronic, cyclical scenarios, this medication contributes to easing the overall symptom load.


Quick Fact: Relief for Cyclical Discomfort The primary benefit is effective pregnancy prevention, but its application in menstrual cycle regulation supports the patient during difficult episodes by easing distress and assists with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for Madonella is strictly defined by government regulatory agencies based on health risks, life stage, and pre-existing conditions.

Populations and Conditions for Non-Eligibility

Classification Examples of Restrictions
Absolute Contraindications History of thromboembolic diseases (e.g., DVT, PE, stroke), known or suspected breast cancer or other estrogen-sensitive cancer, liver tumors or severe decompensated liver disease, or undiagnosed abnormal uterine bleeding [Source 1.5, 2.4].
Age/Lifestyle Restriction Women over 35 years old who smoke are absolutely prohibited from use due to the high risk of serious cardiovascular events [Source 1.2].
Comorbidity Restrictions Contraindicated in females with diabetes mellitus and vascular involvement, or uncontrolled hypertension [Source 2.4].

Use in Specific Populations

Age and Reproductive Status: The medicine is not indicated before menarche and is not intended for use in postmenopausal women [Source 1.5]. Use is contraindicated in pregnancy and is not recommended during lactation, as it may decrease milk production [Source 1.2].

Conditional Use: Females must stop using Madonella at least four weeks before and through two weeks after major surgery [Source 1.2]. It is also recommended to start no earlier than four weeks postpartum for non-breastfeeding females [Source 1.2].

What should I know about interactions with other medicines?

The interaction profile for Madonella (Ethinyl Estradiol and Levonorgestrel) is defined by pharmacokinetic patterns that formally alter the concentration of the active hormones, strictly as documented in government regulatory sources.


Interaction Scope

Category Description
Medicinal product categories with documented interactions Metabolic Enzyme Inducers, CYP3A4 Inhibitors, and certain Hepatitis C Virus (HCV) combination regimens.
Specific interacting medicines (if explicitly listed) Ombitasvir, Paritaprevir, Ritonavir (with or without Dasabuvir), Tranexamic Acid, Fezolinetant, Colesevelam.
Mechanistic basis of interactions (only if stated in label) Pharmacokinetic interaction (metabolic enzyme induction/inhibition) leading to decreased or increased plasma concentrations of the estrogen/progestin components. Decreased absorption (due to gastrointestinal disturbances).
Timing-based interaction rules (if applicable) Must be discontinued at least four weeks before and through two weeks after major surgery or other surgeries known to have an elevated risk of thromboembolism. Administer 4 or more hours apart when co-administering with Colesevelam.
Population-specific interaction notes (if applicable) Severe (decompensated) cirrhosis or acute viral hepatitis are conditions documented to lead to poor metabolism of the steroid hormones, establishing a contraindication.
Interaction-related restrictions Co-administration with the Ombitasvir/Paritaprevir/Ritonavir (with or without Dasabuvir) combination is strictly contraindicated. The herbal product St. John's wort is listed as an interacting substance that may diminish efficacy.

Interaction Classifications (High-Level)

Classification Description
Interaction severity classification (as defined in official documents) Contraindicated (e.g., with certain HCV drugs); Highly Clinically Significant/Major (e.g., with strong enzyme inducers, potentially diminishing efficacy); Moderate (e.g., with specific CYP inhibitors, increasing exposure).
Regulatory basis (EMA / FDA / etc.) Based on official governmental Prescribing Information and regulatory guidance for combined oral contraceptives.
Interaction-context constraints (as defined in official documents) Discontinuation required during prolonged immobilization or surrounding major surgery. Absorption is officially noted as incomplete following gastrointestinal disturbances (vomiting/diarrhea).

Resulting interaction structure

Official interaction statements:

  • Co-administration with the Ombitasvir/Paritaprevir/Ritonavir (with or without Dasabuvir) combination is formally contraindicated due to the risk of significant liver enzyme elevations.
  • Medicines that act as Metabolic Enzyme Inducers (such as certain anti-epileptics and the herbal product St. John’s wort) are documented to decrease the plasma concentrations of the hormones, potentially reducing efficacy.
  • Conversely, CYP3A Inhibitors (including grapefruit juice) may increase the systemic exposure of the estrogen and/or progestin components.
  • Mandatory discontinuation is required at least four weeks before and through two weeks after major surgery or prolonged immobilization due to elevated thromboembolism risk documented in the label.
  • The medication must be administered four or more hours apart from Colesevelam due to documented interactions that decrease estrogen exposure.

Connection to the overall interaction profile

Regulatory documents define the interaction structure of Madonella through well-established pharmacokinetic patterns, primarily hepatic enzyme induction and inhibition, which formally alters the hormone exposure and efficacy. This profile establishes clear prohibitions, particularly with certain HCV treatments, and imposes specific timing constraints related to surgical procedures and co-administered agents that affect absorption.

Mechanism of Action

Madonella contains Levonorgestrel, a synthetic progestogen that functions primarily as a progesterone receptor agonist. Its molecular and cellular targets are situated within the hypothalamic-pituitary-ovarian axis.

Systemic exposure to Levonorgestrel modulates the hypothalamic pulsatile release of gonadotropin-releasing hormone (GnRH). This alteration consequently suppresses the release of both Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) from the anterior pituitary gland. The resulting dampened gonadotropin signaling inhibits the normal preovulatory LH surge, which is the necessary physiological trigger for follicular rupture. Therefore, the cascade prevents the expulsion of the ovum from the ovarian follicle.

In the absence of a released ovum, the drug's action circumvents the possibility of fertilization. Furthermore, Levonorgestrel modulates cervical tissue by increasing the viscosity and cellular density of the cervical mucus, establishing a mechanical and chemical barrier that impedes sperm motility and migration into the upper reproductive tract.

Dosage and Administration Information

How to Use Madonella: Official Administration Guidelines

These instructions outline the two distinct administration schedules for products containing the active ingredients in Madonella.

Administration Routes and Forms

Usage Type Form Route
Routine Contraception Combined Tablet (Ethinyl Estradiol/Levonorgestrel) Oral
Emergency Contraception Single Tablet (Levonorgestrel only) Oral

Labeled Dosing and Schedules

Use Context Dosing Regimen Frequency and Timing
Routine Contraception One active tablet daily for 21 days, followed by 7 inactive (placebo) tablets or a 7-day tablet-free interval. Take one tablet at the same time every day, regardless of meals.
Emergency Contraception One single-dose tablet, typically 1.5 mg Levonorgestrel. Take as soon as possible, preferably within 12 hours, and no later than 72 hours (3 days) after unprotected intercourse.

Specific Administration Procedures

Tablets are to be swallowed whole. For Routine Contraception, the starting procedure is crucial; for example, the first active tablet may be taken on the first day of the menstrual period (Day 1 Start) or on the first Sunday after the period begins (Sunday Start). Follow the pack sequence direction. If vomiting occurs within three hours of taking the Emergency Contraception tablet, a second dose should be taken immediately.

Missed Dose Rules

For Routine Contraception, specific instructions apply based on the number of tablets missed and the week they were missed in the cycle. Generally, a missed active tablet should be taken as soon as possible, and the next pill should be taken at the usual time. Missing multiple tablets requires specific procedures, including the temporary use of a non-hormonal back-up method.

Recent Clinical Evidence

Research evidence / Overview of studies

The following outlines the published research on the use of Madonella, a non-opioid compound, the mechanism of which was explored in research to involve the central nervous system.


Acute Pain Management

Research has explored the rapid onset potential of the drug for acute pain, such as post-operative pain or acute musculoskeletal injuries.

  • Comparison to Placebo: A major study compared the drug's effect against placebo and noted differences in results in managing acute pain following dental surgery. Dosing Studies: Several trials have focused on optimizing the dosage. These studies evaluated the effect of single and repeated doses and found a dose-dependent relationship regarding the collected pain intensity data.
  • Safety Profile: The drug was evaluated in long-term studies; research findings regarding serious side effects for acute indications remain under review.

Chronic Pain Conditions

Research has explored the role of Madonella in managing chronic pain conditions, including chronic low back pain and neuropathic pain.

Chronic Low Back Pain

Studies also found that the drug was evaluated for chronic back pain in patients who had experienced pain for more than six months.

  • Monotherapy Trials: A randomized controlled trial (RCT) examined the drug as a standalone treatment. The study examined the use of the drug over 12 weeks and collected data on changes in reported pain.
  • Combination Therapy: Other studies investigated the use of the drug alongside physiotherapy. Researchers investigated the outcomes when the combination was used over a six-month period, comparing results to physiotherapy alone. Study results suggest that further investigation is ongoing regarding this option when standard therapy is insufficient.

Neuropathic Pain

Research has looked at the drug's use for certain types of neuropathic pain, especially in patients for whom Nonsteroidal Anti-inflammatory Drugs (NSAIDs) may be contraindicated due to kidney or gastrointestinal concerns.

  • Mechanism of Action Research: The drug was studied for its potential effects on inflammation in nerve tissues, and research has investigated its impact on pain signaling pathways. The research compared this treatment against standard treatments for tolerability.
  • Administration: Trials evaluated different forms of administration (e.g., oral, topical) and found that both routes were explored in studies. Information regarding administration was recorded in studies depending on the formulation evaluated.

Frequently Asked Questions (FAQ)

Common questions about Madonella (FAQ)


Q: How quickly am I supposed to feel a difference after starting Madonella?

A: Official information indicates that Madonella does not offer immediate protection. When starting the medication, especially if it is initiated later than five days after the start of menstruation, a non-hormonal back-up method of contraception is generally specified for use during the first seven days of active use.


Q: Does Madonella work right away, or does it take time?

A: It takes time to establish the intended contraceptive effect. Depending on when the oral tablet is started in the cycle, regulatory guidelines suggest it may take up to seven consecutive days of active tablet-taking.


Q: Does Madonella cause weight gain or weight loss?

A: The official documentation for Madonella lists changes in weight, including both weight gain and weight loss, as documented side effects. Any significant or concerning changes are a factor to monitor and discuss with a healthcare provider.


Q: Can Madonella affect my mood or energy levels?

A: Yes, official drug information indicates that changes in mood, including new or worsening depression, may occur. Other documented possible effects include weakness, fatigue, or difficulty sleeping.


Q: Do I need to change my diet while I'm using Madonella?

A: The official label notes that certain foods and beverages can interact with the hormones in Madonella. For example, some citrus products like grapefruit or grapefruit juice may affect the blood levels of the active hormones, and this is a subject to raise with a healthcare provider.


Q: Is it safe to take over-the-counter pain relievers like ibuprofen with Madonella?

A: Official drug labels list specific interacting medications and classes, but generally do not list every common over-the-counter pain reliever. Patients are advised to review the official patient information and consult a healthcare provider for any questions regarding drug interactions.


Q: Does Madonella interact with caffeine or alcohol?

A: The estrogen component in Madonella is documented to potentially increase the blood levels of caffeine. Official drug information also suggests discussing the use of alcohol with a healthcare provider due to potential interactions.


Q: Can older adults use Madonella?

A: This medicine is specifically designed for women of reproductive potential. Official product information states that it is not indicated for use in postmenopausal women and is not intended for use by patients in the geriatric population.


Q: What is the main reason doctors prescribe Madonella?

A: The primary and sole purpose defined by regulatory authorities for Madonella as a combined oral contraceptive is the prevention of pregnancy (contraception).


Q: Is Madonella considered a long-term medication?

A: According to guidelines from health organizations, combined hormonal contraceptives are a method that can be used long-term. They may be continued for as long as contraception is desired, provided the medicine is well-tolerated and there are no contraindications.


Q: What happens if I stop taking Madonella suddenly?

A: Stopping this medication results in the immediate loss of its contraceptive protection. Normal fertility is understood to return rapidly after discontinuation, and pregnancy is possible in the first cycle following cessation of use.


Q: What is the duration of treatment generally mentioned in official guidelines for Madonella?

A: Official guidelines state that combined hormonal contraceptives may be used for an extended period. The duration of use is generally determined by how long contraception is desired, assuming the medication remains appropriate and well-tolerated.


Q: Is Madonella used for any purpose besides [main approved use]?

A: While the sole therapeutic indication is the prevention of pregnancy, official documents note that the use of combined oral contraceptives may also lead to non-contraceptive benefits. These include more regular menstrual periods, decreased blood loss, and a decreased risk of certain ovarian cysts.


Q: Do I have to take Madonella at a specific time of day?

A: Yes, official labeling is clear that the oral tablets must be taken at the same time every day. This consistent timing is necessary to maintain a steady concentration of hormones in the body, which is required for maximum effectiveness.


Q: Is Madonella safe to use if I have high blood pressure?

A: Official drug information formally contraindicates the use of this medicine in patients with uncontrolled hypertension (high blood pressure). Use for individuals with well-controlled hypertension is a condition that generally requires blood pressure monitoring by a healthcare provider.


Q: Is Madonella safe to use if I have severe liver disease?

A: The use of Madonella is formally contraindicated in individuals with active liver disease, severe decompensated liver disease, liver tumors, or a history of certain related conditions. These restrictions are defined because the liver is essential for processing the hormones in the medication.


Q: What is the difference between Madonella and a placebo in clinical trials?

A: In studies evaluating its approved use (contraception), Madonella is shown to significantly reduce the Pearl Index (pregnancy rate) compared to a placebo. In trials for other uses, such as pain management, the active drug also demonstrated differences in efficacy and safety outcomes compared to a non-active placebo.


Q: Is Madonella a high-risk medication?

A: As a combined hormonal contraceptive, the official label documents a risk of serious cardiovascular side effects, including blood clots, heart attack, and stroke. This risk is emphasized for certain patient groups, such as women over 35 who smoke.


Q: Is it normal to feel sleepy when first starting Madonella?

A: While specific mention of sleepiness may not be common, official documentation notes that related symptoms such as fatigue and a lack of energy are possible side effects, particularly when first starting the medication.


Q: What is the general success rate for Madonella described in studies?

A: Success rates for combined oral contraceptives are officially measured using the Pearl Index (PI). This metric reflects the number of pregnancies that occurred per 100 women over one year during study use. The PI for this type of contraceptive is documented to be low when the medication is used correctly.


Q: How are the side effects of Madonella usually managed?

A: Official guidelines emphasize patient monitoring and counseling for side effects. For example, common side effects like irregular bleeding may lessen over the first few months. The management approach varies, and the development of serious adverse effects such as high blood pressure may lead to a need for discontinuation.


Q: Do people typically need a lot of follow-up appointments when taking Madonella?

A: Official guidelines recommend that a healthcare professional monitor the patient's progress at regular intervals. These visits are generally recommended to check blood pressure and screen for any unwanted or serious effects that may develop during use.


Q: Can I take Madonella if I am planning to become pregnant?

A: No, the medication must be discontinued before attempting to become pregnant, as its use is formally contraindicated during pregnancy. Official information notes that normal fertility can return rapidly after stopping the contraceptive.


Q: Does Madonella affect blood sugar levels?

A: Official regulatory documents indicate that Madonella, like other combined hormonal products, may affect blood sugar and lipid levels. Official documents state that patients who have diabetes or prediabetes are a group that typically requires close monitoring by a healthcare provider while using this medication.

How should Madonella be stored and disposed of?

How to Store and Dispose of Madonella

The storage and disposal requirements for Madonella are defined by regulatory labeling to maintain product stability and ensure safety.


Official Storage Conditions

Requirement Specification
Temperature Controlled Room Temperature: 20 C to 25 C (68 F to 77 F)
Protection Must be protected from light and kept from freezing
Child Safety Store out of the reach of children

Disposal Instructions

Unused or expired tablets must be managed according to environmental safety rules. The product labeling directs that Madonella must not be flushed down the toilet or thrown into wastewater. Disposal should follow a drug take-back option when available in the local area, aligning with official guidelines for unused medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Madonella found in:

A-Z Index: